Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 25 | 2022 | 338 | 5.950 |
Why?
|
| Nucleus Accumbens | 10 | 2022 | 31 | 3.320 |
Why?
|
| Sex Characteristics | 9 | 2021 | 175 | 1.890 |
Why?
|
| Ethanol | 9 | 2020 | 236 | 1.500 |
Why?
|
| Analgesics, Opioid | 6 | 2022 | 356 | 1.470 |
Why?
|
| Substance-Related Disorders | 5 | 2020 | 608 | 1.380 |
Why?
|
| Reward | 8 | 2022 | 59 | 1.320 |
Why?
|
| Cocaine | 7 | 2022 | 74 | 1.300 |
Why?
|
| Killer Cells, Natural | 3 | 2013 | 211 | 1.180 |
Why?
|
| Opioid-Related Disorders | 2 | 2022 | 327 | 1.170 |
Why?
|
| Fentanyl | 2 | 2022 | 46 | 1.130 |
Why?
|
| Period Circadian Proteins | 3 | 2015 | 68 | 1.130 |
Why?
|
| Motor Activity | 7 | 2015 | 321 | 1.100 |
Why?
|
| Animals | 40 | 2022 | 17734 | 1.050 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2011 | 95 | 1.030 |
Why?
|
| Circadian Clocks | 3 | 2017 | 40 | 1.010 |
Why?
|
| Stress, Psychological | 2 | 2019 | 379 | 1.000 |
Why?
|
| Brain | 7 | 2022 | 1180 | 0.980 |
Why?
|
| Chronobiology Disorders | 2 | 2014 | 5 | 0.980 |
Why?
|
| Alcohol Drinking | 6 | 2018 | 265 | 0.940 |
Why?
|
| Mice | 25 | 2022 | 9096 | 0.940 |
Why?
|
| Analgesia | 1 | 2022 | 25 | 0.920 |
Why?
|
| Hormones | 2 | 2021 | 50 | 0.920 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2020 | 103 | 0.900 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2022 | 110 | 0.870 |
Why?
|
| Valproic Acid | 1 | 2020 | 20 | 0.820 |
Why?
|
| Sleep | 3 | 2022 | 199 | 0.810 |
Why?
|
| Sleep Wake Disorders | 2 | 2017 | 64 | 0.770 |
Why?
|
| Sirtuin 1 | 3 | 2022 | 20 | 0.770 |
Why?
|
| Nerve Tissue Proteins | 6 | 2022 | 390 | 0.770 |
Why?
|
| Aggression | 1 | 2019 | 73 | 0.740 |
Why?
|
| Prefrontal Cortex | 4 | 2022 | 94 | 0.740 |
Why?
|
| Depressive Disorder, Major | 3 | 2020 | 241 | 0.730 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2019 | 4 | 0.730 |
Why?
|
| Fibroblasts | 1 | 2021 | 344 | 0.720 |
Why?
|
| Transcription Factors | 4 | 2022 | 1356 | 0.700 |
Why?
|
| Brain Diseases | 1 | 2019 | 44 | 0.690 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2018 | 32 | 0.690 |
Why?
|
| Longevity | 1 | 2019 | 85 | 0.680 |
Why?
|
| Male | 33 | 2022 | 23132 | 0.680 |
Why?
|
| Vulnerable Populations | 1 | 2017 | 78 | 0.630 |
Why?
|
| Mice, Inbred C57BL | 11 | 2022 | 2857 | 0.620 |
Why?
|
| Dopamine | 3 | 2022 | 86 | 0.610 |
Why?
|
| Anxiety | 3 | 2020 | 310 | 0.610 |
Why?
|
| beta-Endorphin | 2 | 2015 | 9 | 0.580 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2015 | 22 | 0.550 |
Why?
|
| Neurons | 4 | 2022 | 757 | 0.550 |
Why?
|
| Depression | 2 | 2021 | 748 | 0.540 |
Why?
|
| Schizophrenia | 3 | 2022 | 215 | 0.530 |
Why?
|
| Spleen | 2 | 2013 | 450 | 0.520 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 1498 | 0.500 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2015 | 134 | 0.500 |
Why?
|
| CLOCK Proteins | 4 | 2018 | 46 | 0.490 |
Why?
|
| Granzymes | 1 | 2013 | 18 | 0.480 |
Why?
|
| Perforin | 1 | 2013 | 31 | 0.480 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2015 | 157 | 0.480 |
Why?
|
| Dopaminergic Neurons | 3 | 2021 | 30 | 0.470 |
Why?
|
| Behavior | 1 | 2012 | 38 | 0.440 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 159 | 0.430 |
Why?
|
| Humans | 24 | 2022 | 49664 | 0.420 |
Why?
|
| Rats | 7 | 2021 | 1676 | 0.410 |
Why?
|
| Interferon-gamma | 1 | 2013 | 525 | 0.410 |
Why?
|
| Sympathetic Nervous System | 1 | 2010 | 29 | 0.400 |
Why?
|
| Immune System | 1 | 2011 | 129 | 0.390 |
Why?
|
| Computational Biology | 1 | 2012 | 295 | 0.390 |
Why?
|
| Transcriptome | 4 | 2021 | 287 | 0.380 |
Why?
|
| Female | 18 | 2022 | 26336 | 0.360 |
Why?
|
| Cocaine-Related Disorders | 2 | 2020 | 66 | 0.360 |
Why?
|
| Metabolic Diseases | 2 | 2021 | 41 | 0.350 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 437 | 0.320 |
Why?
|
| Biological Clocks | 3 | 2009 | 67 | 0.300 |
Why?
|
| Glutamic Acid | 3 | 2022 | 71 | 0.300 |
Why?
|
| Locomotion | 3 | 2021 | 102 | 0.280 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 142 | 0.280 |
Why?
|
| Behavior, Animal | 2 | 2018 | 184 | 0.280 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 1787 | 0.270 |
Why?
|
| Mental Disorders | 1 | 2012 | 669 | 0.270 |
Why?
|
| Corpus Striatum | 3 | 2022 | 77 | 0.260 |
Why?
|
| Central Nervous System Depressants | 4 | 2015 | 29 | 0.260 |
Why?
|
| Periodicity | 1 | 2023 | 51 | 0.240 |
Why?
|
| Aging | 2 | 2021 | 680 | 0.230 |
Why?
|
| Hyperalgesia | 1 | 2022 | 12 | 0.230 |
Why?
|
| Drug Tolerance | 1 | 2022 | 24 | 0.230 |
Why?
|
| Cytokines | 2 | 2021 | 817 | 0.230 |
Why?
|
| Arousal | 1 | 2022 | 49 | 0.230 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 296 | 0.230 |
Why?
|
| Wakefulness | 1 | 2022 | 43 | 0.230 |
Why?
|
| NAD | 2 | 2022 | 36 | 0.220 |
Why?
|
| Ventral Tegmental Area | 2 | 2020 | 29 | 0.220 |
Why?
|
| Electroencephalography | 1 | 2022 | 114 | 0.220 |
Why?
|
| Analgesics | 1 | 2022 | 89 | 0.220 |
Why?
|
| Hypothalamus | 2 | 2012 | 124 | 0.220 |
Why?
|
| Vesicular Glutamate Transport Proteins | 1 | 2021 | 1 | 0.220 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2021 | 3 | 0.220 |
Why?
|
| Astrocytes | 1 | 2022 | 94 | 0.210 |
Why?
|
| Parkinsonian Disorders | 1 | 2021 | 8 | 0.210 |
Why?
|
| Eye Movements | 1 | 2022 | 82 | 0.210 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2021 | 30 | 0.210 |
Why?
|
| Glucagon | 1 | 2021 | 29 | 0.210 |
Why?
|
| Genetics | 1 | 2021 | 10 | 0.210 |
Why?
|
| Mutation | 3 | 2020 | 2190 | 0.210 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 41 | 0.210 |
Why?
|
| Antipsychotic Agents | 2 | 2021 | 282 | 0.210 |
Why?
|
| Neurosciences | 1 | 2021 | 24 | 0.210 |
Why?
|
| Histone Deacetylase 2 | 1 | 2020 | 15 | 0.210 |
Why?
|
| Nerve Degeneration | 1 | 2021 | 60 | 0.200 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 26 | 0.200 |
Why?
|
| Models, Biological | 4 | 2017 | 1096 | 0.200 |
Why?
|
| Species Specificity | 3 | 2020 | 310 | 0.200 |
Why?
|
| Molecular Biology | 1 | 2021 | 60 | 0.200 |
Why?
|
| Drinking | 2 | 2018 | 13 | 0.190 |
Why?
|
| Software | 1 | 2023 | 327 | 0.190 |
Why?
|
| Blotting, Western | 2 | 2012 | 534 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 499 | 0.190 |
Why?
|
| Pain | 1 | 2022 | 309 | 0.190 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 135 | 0.190 |
Why?
|
| Social Behavior | 1 | 2019 | 83 | 0.180 |
Why?
|
| Conditioning, Operant | 1 | 2018 | 13 | 0.170 |
Why?
|
| Clozapine | 1 | 2018 | 28 | 0.170 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 684 | 0.170 |
Why?
|
| Receptors, Dopamine | 1 | 2017 | 11 | 0.170 |
Why?
|
| Genotype | 1 | 2020 | 590 | 0.170 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 110 | 0.170 |
Why?
|
| Synapses | 1 | 2019 | 142 | 0.160 |
Why?
|
| Lithium | 1 | 2017 | 14 | 0.160 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 276 | 0.160 |
Why?
|
| Norepinephrine | 2 | 2021 | 76 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 816 | 0.150 |
Why?
|
| Mood Disorders | 1 | 2016 | 59 | 0.150 |
Why?
|
| Fasting | 1 | 2015 | 43 | 0.150 |
Why?
|
| Insulin | 2 | 2021 | 658 | 0.150 |
Why?
|
| Dopamine Uptake Inhibitors | 3 | 2020 | 14 | 0.140 |
Why?
|
| Self Administration | 3 | 2020 | 41 | 0.140 |
Why?
|
| Synaptic Transmission | 3 | 2022 | 113 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 235 | 0.140 |
Why?
|
| Lithium Chloride | 1 | 2015 | 1 | 0.140 |
Why?
|
| Running | 1 | 2015 | 56 | 0.140 |
Why?
|
| Drosophila Proteins | 1 | 2021 | 665 | 0.140 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2015 | 16 | 0.140 |
Why?
|
| Corticosterone | 1 | 2015 | 19 | 0.140 |
Why?
|
| Body Temperature | 1 | 2015 | 44 | 0.140 |
Why?
|
| Antimanic Agents | 1 | 2015 | 28 | 0.140 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2015 | 21 | 0.140 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 136 | 0.140 |
Why?
|
| Maze Learning | 1 | 2015 | 46 | 0.140 |
Why?
|
| Amygdala | 1 | 2015 | 49 | 0.140 |
Why?
|
| Restraint, Physical | 1 | 2015 | 31 | 0.140 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 170 | 0.130 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 155 | 0.130 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 3 | 0.130 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 243 | 0.130 |
Why?
|
| Inflammation | 1 | 2021 | 981 | 0.130 |
Why?
|
| ARNTL Transcription Factors | 1 | 2013 | 25 | 0.120 |
Why?
|
| Blood Glucose | 1 | 2015 | 441 | 0.120 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 293 | 0.110 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 55 | 0.110 |
Why?
|
| Photoperiod | 1 | 2012 | 37 | 0.110 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 78 | 0.110 |
Why?
|
| Autonomic Nervous System | 1 | 2011 | 28 | 0.110 |
Why?
|
| Work Schedule Tolerance | 1 | 2011 | 25 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 821 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 187 | 0.110 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 250 | 0.110 |
Why?
|
| Sympathectomy, Chemical | 1 | 2010 | 1 | 0.100 |
Why?
|
| Guanethidine | 1 | 2010 | 3 | 0.100 |
Why?
|
| Sympatholytics | 1 | 2010 | 4 | 0.100 |
Why?
|
| Adolescent | 2 | 2017 | 5323 | 0.100 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 130 | 0.100 |
Why?
|
| Time Factors | 3 | 2015 | 3127 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 496 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 606 | 0.090 |
Why?
|
| Rats, Long-Evans | 2 | 2005 | 19 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 587 | 0.090 |
Why?
|
| Pregnancy | 1 | 2015 | 2088 | 0.080 |
Why?
|
| RNA | 1 | 2010 | 360 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 1114 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2019 | 904 | 0.070 |
Why?
|
| Cosmetics | 1 | 2005 | 14 | 0.070 |
Why?
|
| Terpenes | 1 | 2005 | 24 | 0.070 |
Why?
|
| Seizures | 1 | 2005 | 84 | 0.070 |
Why?
|
| Workflow | 1 | 2023 | 50 | 0.060 |
Why?
|
| Brain Stem | 1 | 2021 | 29 | 0.050 |
Why?
|
| Rotenone | 1 | 2021 | 8 | 0.050 |
Why?
|
| Rats, Inbred Lew | 1 | 2021 | 79 | 0.050 |
Why?
|
| Adrenergic Agents | 1 | 2021 | 9 | 0.050 |
Why?
|
| Insecticides | 1 | 2021 | 29 | 0.050 |
Why?
|
| Administration, Intravenous | 1 | 2020 | 49 | 0.050 |
Why?
|
| Rodentia | 1 | 2020 | 19 | 0.050 |
Why?
|
| Synaptic Vesicles | 1 | 2020 | 24 | 0.050 |
Why?
|
| Pancreas | 1 | 2021 | 130 | 0.050 |
Why?
|
| Anhedonia | 1 | 2020 | 6 | 0.050 |
Why?
|
| Gonadal Hormones | 1 | 2020 | 5 | 0.050 |
Why?
|
| Light | 2 | 2015 | 192 | 0.050 |
Why?
|
| Nerve Net | 1 | 2020 | 76 | 0.050 |
Why?
|
| Pituitary-Adrenal System | 1 | 2020 | 55 | 0.050 |
Why?
|
| Biological Transport | 1 | 2020 | 269 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 85 | 0.050 |
Why?
|
| Affect | 1 | 2020 | 110 | 0.050 |
Why?
|
| Cell Survival | 1 | 2021 | 528 | 0.050 |
Why?
|
| Behavior, Addictive | 1 | 2020 | 76 | 0.050 |
Why?
|
| Adult | 3 | 2021 | 13331 | 0.050 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2018 | 1 | 0.040 |
Why?
|
| Receptor, Muscarinic M4 | 1 | 2018 | 2 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 32 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2018 | 53 | 0.040 |
Why?
|
| Action Potentials | 1 | 2018 | 87 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2018 | 112 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 182 | 0.040 |
Why?
|
| Drosophila | 1 | 2021 | 427 | 0.040 |
Why?
|
| Neuroglia | 1 | 2018 | 70 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2021 | 1161 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2017 | 80 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2018 | 755 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 154 | 0.040 |
Why?
|
| Physical Conditioning, Animal | 1 | 2015 | 30 | 0.040 |
Why?
|
| Proteomics | 1 | 2017 | 198 | 0.040 |
Why?
|
| Gene Expression | 1 | 2018 | 755 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 275 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 1873 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 378 | 0.030 |
Why?
|
| Genome, Human | 1 | 2015 | 214 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 518 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 2064 | 0.030 |
Why?
|
| Algorithms | 1 | 2018 | 883 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2018 | 668 | 0.030 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2012 | 3 | 0.030 |
Why?
|
| alpha-MSH | 1 | 2012 | 3 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 14 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2012 | 26 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2017 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2012 | 226 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 64 | 0.030 |
Why?
|
| Middle Aged | 2 | 2019 | 13450 | 0.030 |
Why?
|
| Age Factors | 1 | 2012 | 1410 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 536 | 0.020 |
Why?
|
| Triazolam | 1 | 2007 | 3 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 2007 | 12 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2007 | 99 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2007 | 129 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 48 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2007 | 79 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2007 | 67 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 4220 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 360 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 3701 | 0.020 |
Why?
|
| Camphor | 1 | 2005 | 1 | 0.020 |
Why?
|
| Chronobiology Phenomena | 1 | 2005 | 2 | 0.020 |
Why?
|
| Activity Cycles | 1 | 2005 | 3 | 0.020 |
Why?
|
| Intellectual Disability | 1 | 2005 | 148 | 0.010 |
Why?
|
| Alcoholism | 1 | 2005 | 253 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 10870 | 0.010 |
Why?
|
| Infant | 1 | 2005 | 1387 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2005 | 1699 | 0.010 |
Why?
|